Audited Results of Sanofi India Ltd. Company

(Rs in Cr.)	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Income	1,837.40	2,013.20	2,851.10	2,770.10	2,956.60
Manufacturing Expenses	14.60	11.60	14.60	14.30	13.90
Personnel Expenses	185.30	240.20	370.60	405.90	433.90
Selling Expenses	18.10	17.90	40.90	33.80	46.20
Administrative Expenses	230.50	273.30	419.80	421.90	391.80
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,346.10	1,522.40	2,047.10	2,065.70	2,194.10
Operating Profit	491.30	490.80	804	704.40	762.50
Other Recurring Income	19.70	16.50	65.30	71.50	74.40
Adjusted PBDIT	511	507.30	869.30	775.90	836.90
Financial Expenses	1.70	1.50	1.70	1.70	1.80
Depreciation	37.30	36.70	39.60	41.90	66.70
Other Write offs	0	0	0	0	0
Adjusted PBT	472	469.10	828	732.30	768.40
Tax Charges	118	117.70	242.60	243.70	313.20
Adjusted PAT	354	351.40	585.40	488.60	455.20
Non Recurring Items	-25.60	69.30	16.50	132.50	485.90
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	326.70	413.50	603.20	620.60	944.40
Equity Dividend	442.20	384.60	843.20	1,573	840.60
Preference Dividend	0	0	0	0	0
Retained Earnings	332	638	601.90	843.20	1,795.10

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article